Elevance Health Inc
ELV359.070USD
0.000
Fechamento 12/15, 16:00（ET）Cotações atrasadas em 15 min
79.73BValor de mercado
14.60P/L TTM
Mais detalhes de Elevance Health Inc Empresa
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Informações de Elevance Health Inc
Código da empresaELV
Nome da EmpresaElevance Health Inc
Data de listagemOct 30, 2001
CEOBoudreaux (Gail K)
Número de funcionários103158
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 30
Endereço220 Virginia Avenue
CidadeINDIANAPOLIS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46204
Telefone18003311476
Sitehttps://www.elevancehealth.com/
Código da empresaELV
Data de listagemOct 30, 2001
CEOBoudreaux (Gail K)
Executivos da empresa Elevance Health Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Ratnakar V. Lavu
Mr. Ratnakar V. Lavu
Executive Vice President and Chief Digital Information Officer
Executive Vice President and Chief Digital Information Officer
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+6.87%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+13.90%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+14.35%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+3.99%
Ms. Deanna D. Strable-soethout
Ms. Deanna D. Strable-soethout
Independent Director
Independent Director
1.65K
+57.51%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
--
Detalhamento da receita
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Premiums
41.27B
0.00%
Product revenue
6.04B
0.00%
Service fees
2.11B
0.00%
Reconciliation
355.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Distribuição de ações
Atualizado em: ter, 18 de nov
Atualizado em: ter, 18 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Outro
74.16%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Outro
74.16%
Tipos de investidores
Investidores
Proporção
Investment Advisor
49.97%
Investment Advisor/Hedge Fund
30.87%
Pension Fund
2.77%
Bank and Trust
2.31%
Hedge Fund
2.17%
Research Firm
2.06%
Sovereign Wealth Fund
1.41%
Family Office
0.27%
Family Office
0.27%
Outro
7.92%
Participação acionária institucional
Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
3063
205.92M
97.95%
+22.74K
2025Q3
3138
205.95M
97.05%
-3.45M
2025Q2
3116
209.73M
96.68%
-566.57K
2025Q1
3115
208.90M
96.86%
-10.38M
2024Q4
3105
212.00M
93.76%
+298.05K
2024Q3
2993
212.22M
94.67%
-2.15M
2024Q2
2959
214.26M
94.25%
+1.04M
2024Q1
2925
213.00M
94.22%
-6.19M
2023Q4
2869
213.96M
93.90%
-1.80M
2023Q3
2746
215.71M
93.86%
-2.17M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
22.75M
10.1%
-140.75K
-0.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.62M
5.16%
-183.35K
-1.55%
Jun 30, 2025
State Street Investment Management (US)
10.57M
4.69%
-78.72K
-0.74%
Jun 30, 2025
Wellington Management Company, LLP
6.32M
2.81%
+523.40K
+9.03%
Jun 30, 2025
Sanders Capital, LLC
5.83M
2.59%
+1.15M
+24.66%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.75M
3.44%
-1.01M
-11.48%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.09M
2.26%
-72.83K
-1.41%
Jun 30, 2025
Artisan Partners Limited Partnership
3.68M
1.63%
+324.40K
+9.68%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
3.20M
1.42%
-41.22K
-1.27%
Jun 30, 2025
Harris Associates L.P.
2.29M
1.02%
+7.41K
+0.32%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares U.S. Healthcare Providers ETF
4.43%
Monarch Dividend Plus Index ETF
3.25%
John Hancock Fundamental All Cap Core ETF
2.45%
GMO US Quality ETF
2.35%
VictoryShares Free Cash Flow ETF
2.32%
Bushido Capital US Equity ETF
2.2%
State Street SPDR S&P Health Care Services ETF
2.11%
First Eagle Global Equity ETF
2.03%
First Trust Total US Market AlphaDEX ETF
1.75%
First Trust Health Care Alphadex Fund
1.71%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção4.43%
Monarch Dividend Plus Index ETF
Proporção3.25%
John Hancock Fundamental All Cap Core ETF
Proporção2.45%
GMO US Quality ETF
Proporção2.35%
VictoryShares Free Cash Flow ETF
Proporção2.32%
Bushido Capital US Equity ETF
Proporção2.2%
State Street SPDR S&P Health Care Services ETF
Proporção2.11%
First Eagle Global Equity ETF
Proporção2.03%
First Trust Total US Market AlphaDEX ETF
Proporção1.75%
First Trust Health Care Alphadex Fund
Proporção1.71%
Dividendo
Um total de
6.19B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 15, 2025
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
Dec 05, 2025
Dec 19, 2025
Dec 05, 2025
Jul 17, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
Sep 10, 2025
Sep 25, 2025
Sep 10, 2025
Apr 22, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
Jun 10, 2025
Jun 25, 2025
Jun 10, 2025
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
Perguntas frequentes
Quem são os cinco principais acionistas de Elevance Health Inc?
Os cinco principais acionistas de Elevance Health Inc são:
The Vanguard Group, Inc. detém 22.75M Ações, representando 10.10% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 11.62M Ações, representando 5.16% do total de Ações.
State Street Investment Management (US) detém 10.57M Ações, representando 4.69% do total de Ações.
Wellington Management Company, LLP detém 6.32M Ações, representando 2.81% do total de Ações.
Sanders Capital, LLC detém 5.83M Ações, representando 2.59% do total de Ações.
The Vanguard Group, Inc. detém 22.75M Ações, representando 10.10% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 11.62M Ações, representando 5.16% do total de Ações.
State Street Investment Management (US) detém 10.57M Ações, representando 4.69% do total de Ações.
Wellington Management Company, LLP detém 6.32M Ações, representando 2.81% do total de Ações.
Sanders Capital, LLC detém 5.83M Ações, representando 2.59% do total de Ações.
Quais são os três principais tipos de acionistas de Elevance Health Inc?
Os três principais tipos de acionistas da Elevance Health Inc são:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Quantas instituições possuem ações da Elevance Health Inc (ELV)?
Em 2025Q4, 3063 instituições possuíam ações da Elevance Health Inc, com valor de mercado aproximado de 205.92M, representando 97.95% do total de ações. Em comparação com 2025Q3, a participação institucional aumentou em 0.90%.
Qual é a maior fonte de receita da Elevance Health Inc?
Em FY2025Q2, o segmento de negócios Premiums gerou a maior receita para Elevance Health Inc, totalizando 41.27B e representando --% da receita total.
